QA: Indivior Pharmaceuticals Inc in us_pharma/2025

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001625297_2026_Indivior_Pharmaceuticals_Inc.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001625297, Indivior Pharmaceuticals Inc

  xvar xval
0 AssetsCurrent 652,000,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 144,000,000
3 remainder_Assets 405,000,000
4 LiabilitiesCurrent 914,000,000
5 LiabilitiesNoncurrent 333,000,000
6 remainder_Liabilities 53,000,000
7 CostOfGoodsAndServicesSold 246,000,000
8 SellingGeneralAndAdministrativeExpense 634,000,000
9 ResearchAndDevelopmentExpense 97,000,000
10 remainder_Expenses 71,000,000
11 remainder_Revenues 1,239,000,000
12 remainder_NetIncome 19,000,000
13 remainder_ComprehensiveNetIncome 6,000,000
  yvar yval
0 Assets 1,201,000,000
1 Liabilities 1,300,000,000
2 Expenses 1,048,000,000
3 Revenues 1,239,000,000
4 StockholdersEquity -99,000,000
5 NetIncome 210,000,000
6 ComprehensiveNetIncome 213,000,000
7 BaseVar 2,406,500,000
8 EconomicCapitalRatiobeforeLimitedLiability -0.00226
9 EconomicCapitalRatio 1.41

Edgar->Model Mapping

Feature Distribution

Change over Time